Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Depressive Symptoms Linked to Motoric Cognitive Risk

May 5, 2026
Continue Reading
depressive-symptoms-linked-to-motoric-cognitive-risk
Posted inBiotechnology

Predicting Coronary Artery Aneurysms in Kawasaki Disease

May 5, 2026
Continue Reading
predicting-coronary-artery-aneurysms-in-kawasaki-disease
Posted inBiotechnology

Breakthrough Study Advances Personalized Treatment for Parkinson’s Disease

May 5, 2026
Continue Reading
breakthrough-study-advances-personalized-treatment-for-parkinson’s-disease
Posted inBiotechnology

School Fitness Testing: Challenges and New Opportunities

May 5, 2026
Continue Reading
school-fitness-testing:-challenges-and-new-opportunities
Posted inBiotechnology

ZNF473 Drives Colorectal Cancer, Boosts Chemoresistance

May 5, 2026
Continue Reading
znf473-drives-colorectal-cancer,-boosts-chemoresistance
Posted inBiotechnology

All-Metal Biodegradable Microrobots Set to Revolutionize Drug Delivery and Biopsy Techniques

May 5, 2026
Continue Reading
all-metal-biodegradable-microrobots-set-to-revolutionize-drug-delivery-and-biopsy-techniques
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

ikena,-after-tough-year-of-layoffs,-merges-with-inmagene-to-focus-on-phase-2-dermatitis-prospect
Posted inBiotechnology

Ikena, after tough year of layoffs, merges with Inmagene to focus on phase 2 dermatitis prospect

December 23, 2024
After a year that saw Ikena Oncology trim back its workforce and pipeline, the oncology biotech thinks it has found…
Read More
rapt-re-rolls-after-flameout,-paying-$35m-for-challenger-to-novartis,-roche-drug
Posted inBiotechnology

Rapt re-rolls after flameout, paying $35M for challenger to Novartis, Roche drug

December 23, 2024
Rapt Therapeutics has charted a new course following the implosion of its lead program, agreeing to pay $35 million for a…
Read More
sanofi-pays-sk-bioscience-e50m-as-children’s-pneumococcal-vaccine-enters-phase-3
Posted inBiotechnology

Sanofi pays SK bioscience €50M as children’s pneumococcal vaccine enters phase 3

December 23, 2024
Sanofi is handing SK bioscience 50 million euros ($52 million) as the longtime partners take their next-gen pneumococcal conjugate vaccine…
Read More
phase-2-data-will-drive-biopharma-vc-investments-next-year:-pitchbook
Posted inBiotechnology

Phase 2 data will drive biopharma VC investments next year: PitchBook

December 23, 2024
Phase 2 trial data will continue to be the name of the game when it comes to VC investments into…
Read More
stockwatch:-wall-street’s-leaders-and-laggards-of-2024
Posted inGenetics

StockWatch: Wall Street’s Leaders and Laggards of 2024

December 21, 2024
2024 had its dazzling moments, but, in the end, it was a year of treading water for biopharma stocks, judging…
Read More
Posted inBiotechnology

Discover Astellas’ differentiated approach to innovation partnerships

December 20, 2024
As a global life sciences company, Astellas is passionate about partnering to advance life-changing treatments for patients. If you are…
Read More
clinical-trials-industry-to-grapple-with-new-tech,-additional-uncertainty-in-2025:-velocity-clinical-research-ceo
Posted inResearch

Clinical trials industry to grapple with new tech, additional uncertainty in 2025: Velocity Clinical Research CEO

December 20, 2024
Clinical trials in 2025 will be beset by rising costs and uncertain regulations while also benefiting from new technologies and…
Read More
galectin’s-mash-treatment-reduces-varices-but-fails-to-hit-statistical-significance-in-phase-3-trial
Posted inBiotechnology

Galectin’s MASH treatment reduces varices but fails to hit statistical significance in phase 3 trial

December 20, 2024
Galectin Therapeutics’ stock has halved since the company revealed its investigational drug failed to significantly reduce enlarged veins for people…
Read More
clinical-research-company-javara-lays-off-employees-as-part-of-restructuring
Posted inResearch

Clinical research company Javara lays off employees as part of restructuring

December 20, 2024
Clinical research firm Javara has laid off staff as part of a restructuring, a spokesperson confirmed to Fierce Biotech in…
Read More
applied-therapeutics-ceo-steps-down-in-wake-of-fda-rejection,-warning-letter-and-investor-lawsuit
Posted inBiotechnology

Applied Therapeutics CEO steps down in wake of FDA rejection, warning letter and investor lawsuit

December 20, 2024
A turbulent month at Applied Therapeutics is being capped off with the departure of CEO and chair Shoshana Shendelman, Ph.D.,…
Read More

Posts pagination

Previous page 1 … 1,768 1,769 1,770 1,771 1,772 … 1,784 Next page
You May Have Missed
nuvalent-teams-up-with-guardant-health-for-companion-diagnostics
Posted inMedical Technology

Nuvalent teams up with Guardant Health for companion diagnostics

genomics-inks-partnership-deal-with-greywolf-to-assess-gene-datasets
Posted inMedical Technology

Genomics inks partnership deal with Greywolf to assess gene datasets

labcorp-raises-full-year-guidance,-boosted-by-diagnostics,-lab-services
Posted inMedical Technology

Labcorp raises full-year guidance, boosted by diagnostics, lab services

caredx-expands-into-cancer-testing-with-$260m-naveris-buy
Posted inMedical Technology

CareDx expands into cancer testing with $260M Naveris buy

Privacy Policy    Terms

Scroll to Top